Premium
In a setback for the lenders of Sterling Biotech, the Mumbai bench of the National Company Law Tribunal (NCLT) has called for the liquidation of the debt-ridden pharmaceutical company after rejecting the lenders’ petition to withdraw the firm’s insolvency proceedings. The court took the decision to liquidate the company on grounds ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
